Ticker Details
Aquestive Therapeutics, Inc.
IPO Date:	July 23, 2018
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$584.88M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.17 | 3.98%
Avg Daily Range (30 D):	$0.10 | 2.51%
Avg Daily Range (90 D):	$0.10 | 2.39%

Institutional Daily Volume
Avg Daily Volume:	1.01M
Avg Daily Volume (30 D):	2.85M
Avg Daily Volume (90 D):	2.03M

Trade Size
Avg Trade Size (Sh.):	177
Avg Trade Size (Sh.) (30 D):	173
Avg Trade Size (Sh.) (90 D):	156

Institutional Trades
Total Institutional Trades:	344
Avg Institutional Trade:	$1.54M
Avg Institutional Trade (30 D):	$1.29M
Avg Institutional Trade (90 D):	$1.41M
Avg Institutional Trade Volume:	.35M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.51M
Avg Closing Trade (30 D):	$.82M
Avg Closing Trade (90 D):	$1.22M
Avg Closing Volume:	326.44K

News

May 2, 2026 @ 8:00 PM AQST DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Enco... Source: Rosen Law Firm

Apr 30, 2026 @ 4:00 PM Bronstein, Gewirtz & Grossman LLC Urges Atara Biot... Source: Bronstein, Gewirtz & Grossman Llc

Apr 30, 2026 @ 12:04 AM Bragar Eagel & Squire, P.C. Reminds Aquestive Ther... Source: Bragar Eagel & Squire, P.C.

Apr 28, 2026 @ 1:00 PM Portnoy Law Firm Announces Class Action on Behalf ... Source: Portnoy Law Firm

Apr 27, 2026 @ 4:00 PM Bronstein, Gewirtz & Grossman LLC Urges Aquestive ... Source: Bronstein, Gewirtz & Grossman Llc

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.18	$-.07	$-.27
Diluted EPS	$-.18	$-.07	$-.27
Revenue	$13.82M	$14.45M	$13.02M
Gross Profit	$9.8M	$10.98M	$7.18M
Net Income / Loss	$-22.86M	$-8.06M	$-31.86M
Operating Income / Loss	$-8.22M	$-4.2M	$-28.84M
Cost of Revenue	$4.02M	$3.47M	$5.84M
Net Cash Flow	$-12.24M	$-10.44M	$-7.89M
PE Ratio